Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow OPKO HEALTH, INC.

Get SEC filing alerts via email and in your feed for OPKO HEALTH, INC.

OPK

OPKO HEALTH, INC.

About OPKO HEALTH, INC.

OPKO Health is a diversified healthcare company specializing in pharmaceuticals, diagnostics, and biologics. It develops and commercializes therapies like long-acting growth hormone (NGENLA) and treatments for kidney disease, while operating diagnostic labs and advanced biotech pipelines. Its core markets include the U.S., Europe, Asia, and Latin America, leveraging proprietary technologies, strategic partnerships, and a global footprint to address unmet medical needs in endocrinology, oncology, infectious diseases, and personalized medicine.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from OPKO HEALTH, INC.

1
1
OPKO HEALTH, INC. OPKO Health Reports $124.2 Million Revenue in Q1 2026, 17% Decrease Year-Over-Year

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
OPKO HEALTH, INC. OPKO Health Reports 15% Revenue Decline and $225.7 Million Net Loss for 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
OPKO HEALTH, INC. OPKO Health Reports Q3 2025 Revenue of $151.7 Million, Operating Income Turnaround

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
OPKO HEALTH, INC. OPKO Health Reports 14% Revenue Decline and $60M Operating Loss in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
OPKO HEALTH, INC. OPKO Health Reports $149.95 Million Revenue in Q1 2025, 14% Decline Year-Over-Year

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
OPKO HEALTH, INC. OPKO Health Reports $152.1 Million Loss and 17% Revenue Decline for 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
OPKO HEALTH, INC. OPKO Health Reports Mixed Q3 Results with Revenue Decline, Improved Profitability

Via official filing (AI summary) | over 1 year ago | 0 comments